Image Source:

Oxford COVID-19 vaccine may arrive by Sept-Oct 2020

| Oxford University |

After what seemed like forever, it's expected that AstraZeneca - a global biopharmaceutical firm, will soon announce breakthrough results on its pursuit for a COVID-19 vaccine.
The research backing this COVID-19 vaccine breakthrough involves brains from the University of Oxford -- all spearheaded by Sarah Catherine Gilbert, Professor of Vaccinology at the university.
COVID-19 vaccine from Oxford may be the first in the world
The Oxford COVID-19 vaccine, backed by Indian ICMR (as far as we are concerned), is also being trialled and mass-produced by Serum India Institute based in Pune, world's largest producer of vaccine doses by volume. They had announced in April 2020 that the Oxford COVID-19 vaccine that they're trialling should be ready by September and sold at Rs 1,000 per vaccine.
Oxford had started the human trials of its vaccine candidates on 1,100 people towards the end of April. The development phase for the vaccine was mere four months, �a process that normally takes about five years,� mentions the Bloomberg report.
By June end, the team had reached the final stages of human testing and now AstraZeneca is reportedly due to announce the positive results soon. Once so, the vaccine will be in production by as early as September. All other candidates are either still in the initial stages of testing or are yet to start the testing on humans.
So no wonder that the world is waiting on �ChAdOx1 nCoV-19,� the technical name of the vaccine. Sarah Gilbert and her team have managed to leapfrog other vaccine contenders to the point where �it will likely finish vaccinating subjects in its big 10,000-person efficacy trial before other candidates even start testing on that scale,� the report cites Kate Bingham, chair of the U.K. government�s Vaccine Taskforce.